May 14, 2019 / 10:00PM GMT
Ying Huang - BofA Merrill Lynch, Research Division - Director in Equity Research
Let's get started with the next session. So my name is Ying Huang. I'm the senior biotech analyst covering large-cap biotech here at BofA Merrill Lynch. And we're very pleased to have our next presenting company bluebird bio. We have CEO -- well, actually, I should say Chief bluebird, Nick Leschly, from bluebird. And I think...
Nick Leschly - bluebird bio, Inc. - President, CEO & Director
I'm proud of you right now, and that's good.
Ying Huang - BofA Merrill Lynch, Research Division - Director in Equity Research
Thank you. Appreciate it. So, Nick will probably have a few slides and some prepared remarks and then we'll go into Q&A after that. With that, let me welcome Nick to Vegas, I remember last year we had some accident the with the air traffic situation. So I'm glad you are here in (inaudible).
Nick Leschly - bluebird bio, Inc. - President, CEO & Director
(inaudible)
bluebird bio Inc at Bank of America Merrill Lynch Health Care Conference Transcript
May 15, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers